Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function

Cardiovascular Drugs and Therapy

Volumn 13, Issue 3, 1999, Pages 201-209

  Schlaifer, Jay D ^a   Mancini, G B John ^b   O'Neill, Blair J ^c   Pitt, Bertram ^d   Haber, Harry E ^e   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF MICHIGAN   (United States)

^e PFIZER INC   (United States)

Author keywords

Acetylcholine; Angiotensin converting enzyme inhibition; Coronary disease; Endothelium; Smoking; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; QUINAPRIL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SMOKING; VASOCONSTRICTION; VASOMOTOR REFLEX;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY DISEASE; CORONARY VESSELS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; HUMANS; ISOQUINOLINES; MIDDLE AGED; NITROGLYCERIN; RETROSPECTIVE STUDIES; SMOKING; TETRAHYDROISOQUINOLINES; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 0032999628     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007740008155     Document Type: Article

References (36)

1. 1. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: The Framingham Study. Am J Cardiol 1976; 38:46-51.
2. 2. Doll R, Peto R. Mortality in relation to smoking: Twenty years' observations on male British doctors. Br Med J 1976;2:1525-1536.
3. 3. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W, and the INTACT Study Group. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: Relation to clinical events and risk factors. Circulation 1992; 86:828-838.
4. 4. Walters D, Lespérance J, Gladstone P, et al. for the CCAIT Study Group. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. Circulation 1996;94:614-621.
5. 5. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88: 2149-2155.
6. 6. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med 1996;334:150-154.
7. 7. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985;37: 529-533.
8. 8. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med 1989;149:386-389.
9. 9. Lehr HA, Kress E, Menger M, Freidl H, Hubner C, Arfors K. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: Inhibition by CuZn superoxide dismutase. Free Radic Biol Med 1993;14:573-581.
10. 10. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J 1987;113: 1006-1010.
11. 11. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-1514.
12. 12. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056.
13. 13. Mancini GBJ, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 1996;94:258-265.
14. 14. Mancini GBJ, Simon SB, McGillem MJ, Lefree MT, Fried-man HZ, Vogel RA. Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation 1987; 75:452-460.
15. 15. SAS Institute, Inc. SAS/STAT User's Guide. Cary, NC: SAS Institute, 1990.
16. 16. Vliestra RE, Kronmal RA, Oberman A, Frye RL, Killip T. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS Registry. JAMA 1986;255:1023-1027.
17. 17. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986; 314:271-275.
18. 18. Barry J, Mead K, Nabel EG, et al. Effect of smoking on the activity of ischemic heart disease. JAMA 1989;261:398-402.
19. 19. Vlietstra RE, Kronmal RA, Frye RL, et al. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the Coronary Artery Surgery Study. Arteriosclerosis 1982;2:208-215.
20. 20. Buchwald H, Matts JP, Fitch LL, et al. for the POSCH Group. Changes in sequential coronary arteriograms and subsequent coronary events. JAMA 1992;268:1429-1433.
21. 21. Walters D, Craven TE, Lespérance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993;87:1067-1075.
22. 22. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
23. 23. Azen SP, Mack W, Cashin-Hemphill L, et al. Progression of coronary artery disease predicts clinical coronary events: Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 1996;93:34-41.
24. 24. Asmussen I, Kjedsen K. Intimal ultrastructure of human Umbilical arteries. Observations on arteries from newborn children of smoking and non-smoking mothers. Circ Res 1975;36:579-589.
25. 25. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-1492.
26. 26. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-497.
27. 27. Nitenberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med 1993; 95:71-77.
28. 28. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-1100.
29. 29. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34.
30. 30. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-H880.
31. 31. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-H828.
32. 32. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in pig coronary artery. J Clin Invest 1990;86:75-79.
33. 33. Hietzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: Role of oxidized LDL. Circulation 1996;93:1346-1353.
34. 34. Hahn AWA, Jonas U, Bühler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett 1994;347:178-180.
35. 35. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995;95:995-1001.
36. 36. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74;1141-1148.